The WHO has given a green light to widespread use of GlaxoSmithKline's malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The RTS,S/AS01 vaccine ...

GlaxoSmithKline’s experimental malaria vaccine, RTS,S, has proved only 30% effective when administered to babies, as part of Africa’s largest ever clinical trial. There is a lot of pressure on ...

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former ...

According to the World Health Organization (WHO), only access to clean drinking water rivals vaccination in its ability to help save lives (around two to three million each year). For more than ...

GSK’s vaccine portfolio. GSK’s portfolio of more than 20 marketed vaccines, one of the industry’s broadest, protects people against diseases such as meningitis, shingles, polio, measles ...

(CNN)-- For most Americans, mosquitoes are pests whose bites leave behind itchy bumps. But in other parts of the world, mosquitoes carry a disease called malaria that kills more than a million ...

After decades of work, the World Health Organization (WHO) endorsed the first-ever malaria vaccine last year – a historic milestone that promised to drive back a disease that kills a child every ...

The demonstration of efficacy of two candidate malaria vaccines in children living in malaria-endemic areas, namely RTS,S from the circumsporozoite protein that reduced infection and clinical ...

Expert Rev Vaccines. 2008;7(2):223-240. ME-TRAP Oxford University, MVI, Wellcome Trust Multiepitope string expressed in fowlpox and MVA Liver stage IIb CS + LSA1 epitope in attenuated viruses ...